icon-folder.gif   Conference Reports for NATAP  
 
  EASL 46th Annual Meeting
March 30th - April 3rd 2011
Berlin, Germany
Back grey_arrow_rt.gif
 
 
 
Activity of danoprevir plus low-dose ritonavir in combination with peginterferon alfa-2a (40KD) plus ribavirin in previous null responders
 
 
  Reported by Jules Levin EASL 2011 Berlin Germany March 31-April 3
 
R. Rouzier1, D. Larrey2, E.J. Gane3, A. Wiercinska-Drapalo4, L. Chang5, Y. Zhang5, B. Gujral6, S. Le Pogam7, I. Nájera7, P. Smith7, N. Shulman5, J. Tran5 1Centre CAP; 2Saint Eloi Hospital, Montpellier, France; 3Auckland Clinical Studies, Auckland, New Zealand; 4Medical University of Warsaw, Warszawa, Poland; 5Roche, South San Francisco, CA, USA; 6Roche, Welwyn, UK; 7Roche, Nutley, NJ, USA

croi1.gif

croi2.gif

croi3.gif

croi4.gif

croi5.gif

croi6.gif

croi7.gif

croi8.gif